These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33328401)

  • 1. Borderline Case of TAFRO Syndrome and POEMS Syndrome.
    Shibata S; Tabata S; Morita H; Endo T; Kawasaki N; Okamoto Y; Inano S; Takiuchi Y; Fukunaga A; Kitano T
    Intern Med; 2021 May; 60(10):1589-1595. PubMed ID: 33328401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tufted-angioma-like lesion associated with vascular endothelial growth factor and interleukin-6 in TAFRO syndrome: Is it a common histological feature of multicentric Castleman disease/POEMS syndrome?
    Fujita K; Hatta K
    J Cutan Pathol; 2019 Apr; 46(4):280-284. PubMed ID: 30632181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Castleman disease and TAFRO syndrome.
    Masaki Y; Arita K; Sakai T; Takai K; Aoki S; Kawabata H
    Ann Hematol; 2022 Mar; 101(3):485-490. PubMed ID: 35044513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
    Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
    Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
    Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
    Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Castleman Disease.
    Szalat R; Munshi NC
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):53-64. PubMed ID: 29157619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Historical and pathological overview of Castleman disease.
    Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
    J Clin Exp Hematop; 2022 Jun; 62(2):60-72. PubMed ID: 35474035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAFRO Syndrome: A Disease Requiring Immediate Medical Attention.
    Masaki Y; Ueda Y; Yanagisawa H; Arita K; Sakai T; Yamada K; Mizuta S; Fukushima T; Takai K; Aoki S; Kawabata H
    Intern Med; 2023 Jan; 62(1):27-32. PubMed ID: 35598998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical spectrum of Castleman's disease.
    Dispenzieri A; Armitage JO; Loe MJ; Geyer SM; Allred J; Camoriano JK; Menke DM; Weisenburger DD; Ristow K; Dogan A; Habermann TM
    Am J Hematol; 2012 Nov; 87(11):997-1002. PubMed ID: 22791417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.
    Iwaki N; Gion Y; Kondo E; Kawano M; Masunari T; Moro H; Nikkuni K; Takai K; Hagihara M; Hashimoto Y; Yokota K; Okamoto M; Nakao S; Yoshino T; Sato Y
    Sci Rep; 2017 Feb; 7():42316. PubMed ID: 28205564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomeruloid hemangioma associated with TAFRO syndrome.
    Shinozaki-Ushiku A; Higashihara T; Ikemura M; Sato J; Nangaku M; Ushiku T; Fukayama M
    Hum Pathol; 2018 Dec; 82():172-176. PubMed ID: 29702119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Castleman disease in association with POEMS.
    Adelman HM; Cacciatore ML; Pascual JF; Mike JM; Alberts WM; Wallach PM
    Am J Med Sci; 1994 Feb; 307(2):112-4. PubMed ID: 8141136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical Hypothyroidism in TAFRO Syndrome.
    Oka S; Ono K; Nohgawa M
    Intern Med; 2019 Sep; 58(18):2615-2620. PubMed ID: 31178506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.
    Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome.
    D'Souza A; Hayman SR; Buadi F; Mauermann M; Lacy MQ; Gertz MA; Kyle RA; Kumar S; Greipp PR; Lust JA; Russell SJ; Zeldenrust S; Dingli D; Witzig TE; Rajkumar SV; Dispenzieri A
    Blood; 2011 Oct; 118(17):4663-5. PubMed ID: 21881050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Castleman disease of the hyaline vascular variant transforming to POEMS syndrome as endpoint: a case report.
    Ge Y; Da Q; Dai Y
    BMC Neurol; 2018 Oct; 18(1):169. PubMed ID: 30301456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incomplete POEMS syndrome with multicentric Castleman's disease].
    González de la Aleja P; García-Navarro M; Sánchez-Martínez R; Ramos JM
    An Sist Sanit Navar; 2017 Dec; 40(3):475-478. PubMed ID: 28906499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment response and prognosis of POEMS syndrome coexisting with Castleman disease.
    Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Tsuneyama A; Suzuki YI; Nakamura K; Kano H; Kuwabara S
    J Neurol Sci; 2020 Jun; 413():116771. PubMed ID: 32172013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary and Pancreatic: Obliterative portal venopathy found in Castleman disease variant of POEMS syndrome.
    Zhang L; Gao H; Feng Y; Wang G; Zhang X; Li Z
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1311. PubMed ID: 29691905
    [No Abstract]   [Full Text] [Related]  

  • 20. Castleman Disease: A Rare Lymphoproliferative Disorder With Diverse Clinical Presentation, Diagnosis, and Treatment Approach.
    Patel JP; Patel DP; Amin TH; Dave RK; Hardaswani D; Saiyed F; Goswami RJ
    Cureus; 2024 Sep; 16(9):e69149. PubMed ID: 39398672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.